Structure Therapeutics
Structure Therapeutics is seeking an Executive Director, Analytical Development (Small Molecule) to lead analytical development and quality control activities supporting late-stage development, commercialization, and regulatory filings. The role involves strategic oversight of method development, validation, and compliance to ensure high-quality production of small molecule medicines.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2017
Structure Therapeutics is a biopharmaceutical company with the mission 'Medicine is our platform. Accessibility is our cure.' The company is focused on developing medicines with an emphasis on accessibility, and maintains an active pipeline and team as indicated on its website.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Structure Therapeutics.
46% above the average for this role
Senior Director, Analytical Sciences
Mineralys Therapeutics
Principal Scientist, Analytical Development – Drug Substance
MapLight Therapeutics
Associate Director, CMC Analytical Development – Small Molecule
Beeline Medicines
Associate Principal Scientist, Analytical R&D
Merck & Co., Inc.
Analytical Development, Senior Manager
Intuitive
Lead and mentor the Oligonucleotide & Small Molecule CMC Analytical Development team
Denali Therapeutics